Terug
39
59
36
Dagbereik
€ 10,55
€ 10,66
52-Weeksbereik
€ 7,01
€ 11,16
Volume
502.399
50D / 200D Gem.
€ 10,54
/
€ 10,65
Vorige Slotkoers
€ 10,63
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (621 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 12,2 | 12,6 |
| P/B | 3,1 | 3,0 |
| ROE % | 29,5 | 8,9 |
| Net Margin % | 21,3 | 5,6 |
| Rev Growth 5Y % | 16,0 | 9,2 |
| D/E | 0,2 | 0,3 |
Koersdoel Analisten
Hold
€ 11,00
+3.3%
Forward K/W
25,9
Forward WPA
€ 0,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
340 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,52
€ 0,51 – € 0,53
|
390 M | 1 |
| FY2026 |
€ 0,41
€ 0,37 – € 0,45
|
340 M | 1 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2025 |
Singal Gaurav
Chief Technology Officer
|
sell | 14.544 | € 10,61 | € 154.312 |
| Sep 18, 2025 |
Stewart Scott Matthew
Chief Financial Officer
|
sell | 62.830 | € 10,63 | € 667.883 |
| Sep 18, 2025 |
Singal Gaurav
Chief Technology Officer
|
other | 400.000 | € 3,27 | € 1.308.000 |
| Sep 18, 2025 |
Singal Gaurav
Chief Technology Officer
|
sell | 200.000 | € 10,63 | € 2.126.000 |
| Aug 1, 2025 |
Venkatesan Ravi
Chief Executive Officer
|
grant | 14.593 | — | — |
| Aug 1, 2025 |
Stewart Scott Matthew
Chief Financial Officer
|
grant | 20.595 | — | — |
| Aug 1, 2025 |
Singal Gaurav
Chief Technology Officer
|
grant | 7.260 | — | — |
| Aug 1, 2025 |
Grachek Jared Scott
Chief Accounting Officer
|
grant | 3.739 | — | — |
| Aug 1, 2025 |
Novoseletsky Anna Rose
Chief Legal Officer
|
grant | 6.810 | — | — |
| May 12, 2025 |
Smalling Anne M.
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
Harris Ian Jiro
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
Passilla Michael
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
Bergeron Douglas
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
Warren Shannon S
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
RICHEY ELLEN
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
Lamm Jacob
Director
|
grant | 19.157 | — | — |
| May 12, 2025 |
Baird Lisa P.
Director
|
grant | 19.157 | — | — |
| May 1, 2025 |
Passilla Michael
Director
|
grant | 18.727 | — | — |
| May 1, 2025 |
Smalling Anne M.
Director
|
grant | 18.727 | — | — |
| May 1, 2025 |
Lamm Jacob
Director
|
grant | 18.727 | — | — |
Belangrijkste Punten
Revenue grew 16,03% annually over 5 years — strong growth
Earnings grew 438,09% over the past year
ROE of 29,45% indicates high profitability
Net margin of 21,33% shows strong profitability
Debt/Equity of 0,19 — conservative balance sheet
Generating 3,34M in free cash flow
Groei
Revenue Growth (5Y)
16,03%
Revenue (1Y)12,64%
Earnings (1Y)438,09%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
29,45%
ROIC5,54%
Net Margin21,33%
Op. Margin7,38%
Veiligheid
Debt / Equity
0,19
Current Ratio1,86
Interest Coverage8,06
Waardering
P/E Ratio
12,17
P/B Ratio3,09
EV/EBITDA35,05
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,64% | Revenue Growth (3Y) | 11,44% |
| Earnings Growth (1Y) | 438,09% | Earnings Growth (3Y) | 909,69% |
| Revenue Growth (5Y) | 16,03% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 302,55M | Net Income (TTM) | 64,53M |
| ROE | 29,45% | ROA | 16,90% |
| Gross Margin | 40,93% | Operating Margin | 7,38% |
| Net Margin | 21,33% | Free Cash Flow (TTM) | 3,34M |
| ROIC | 5,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,19 | Current Ratio | 1,86 |
| Interest Coverage | 8,06 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 12,17 | P/B Ratio | 3,09 |
| P/S Ratio | 2,60 | PEG Ratio | 0,03 |
| EV/EBITDA | 35,05 | Dividend Yield | 0,00% |
| Market Cap | 785,12M | Enterprise Value | 782,57M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 302,55M | 268,60M | 243,64M | 205,20M | 166,94M |
| Net Income | 64,53M | 11,99M | 633.000,0 | -1,70M | -8,71M |
| EPS (Diluted) | 0,86 | 0,15 | 0,00 | -0,03 | -0,14 |
| Gross Profit | 123,82M | 102,65M | 81,24M | 64,20M | 54,03M |
| Operating Income | 22,33M | 14,17M | 760.000,0 | -2,66M | -8,71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 381,86M | 335,57M | 289,61M | 255,63M | 237,67M |
| Total Liabilities | 128,11M | 151,10M | 122,02M | 95,66M | 83,14M |
| Shareholders' Equity | 253,75M | 184,47M | 167,59M | 159,97M | 154,53M |
| Total Debt | 48,60M | 47,33M | 44,70M | 20,89M | 22,78M |
| Cash & Equivalents | 51,15M | 58,92M | 50,93M | 68,13M | 88,14M |
| Current Assets | 152,93M | 157,79M | 123,38M | 136,58M | 131,28M |
| Current Liabilities | 82,40M | 105,90M | 81,69M | 79,18M | 65,67M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#252 of 326
#12 of 195
Custom
Lower Risk
#110 of 136
Recente Activiteit
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Ingestapt
Value Investing (Warren Buffett)
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026